BIRD Symposium IBD Update May 25th 2019
 
Didier Baert, MD (Maria Middelares, Gent, Belgium)
Maria Middelares, Gent
 

 
Peter Bossuyt, MD (AZ Imelda, Bonheiden, Belgium)
AZ Imelda, Bonheiden
 
Peter Bossuyt is a gastroenterologist and head of the IBD clinic in the Imelda General Hospital in Bonheiden, Belgium. He is also Co-director of the Imelda GI Clinical Research Centre in Bonheiden.
 
Dr Bossuyt studied medicine at the Catholic University of Leuven, Belgium, and graduated in 2004 with magna cum laude. He pursued his GI fellowship in Kortrijk, Roeselare, Bonheiden and Leuven. After completing his GI fellowship, he took up a fellowship in advanced endoscopy at the Academic Medical Centre, Amsterdam. Between 2010 and 2015 he was a consulting staff member for endoscopic ultrasound at the University Hospitals of Leuven. In 2015 he started a PhD entitled, Value of endoscopic scoring and imaging for the prognosis and follow up of IBD, with Professor Séverine Vermeire as promotor. His research focuses on clinical trials in IBD and the definitions of endoscopic and imaging targets in IBD. He is a pioneer in working with e-health tools in IBD in Belgium.
 
He is an editorial board member of the Journal of Crohn’s and Colitis, Chair of the Scientific Committee of the Belgian IBD Research and Development Group, and board member of ECCO’s Clinical Research Committee, ClinCom.

 
Mia Cilissen (Maastricht UMC, The Netherlands)
Maastricht UMC
 

 
Sofie Coenen (UZ Leuven, Belgium)
UZ Leuven
 

 
Anneline Cremer, MD (Hôpital Erasme ULB, Bruxelles, Belgium)
Hôpital Erasme ULB, Bruxelles
 
Anneline Cremer graduated from the Université Libre de Bruxelles (ULB) medical school, Belgium, in 2010. She graduated from the Erasme academic Hospital, ULB, Belgium, in Gastroenterology in 2017 with summa cum laude. Her strong interest for Gastroenterology and more specifically for Inflammatory Bowel Disease (IBD) has grown over the years. During her last year in medical school, she spent 6 months in the Laboratory of Experimental Gastroenterology (LGE), ULB, in Brussels working on a basic immunology project.
 
She started her clinical training in 2010, and started her Gastroenterology training in October 2013 in the Department of Gastroenterology of Tivoli Hospital (La Louvière) for six months followed by one year and a half in the Department of Gastroenterology of ULB-Erasme Hospital. She received a doctoral research fellowship (October 2015-April 2020) from the Fonds Erasme (ULB). She also participated as co-investigator in clinical trials in the field of Crohn's Disease and Ulcerative Colitis since November 2015.
 
She is currently working half time in clinic in the Department of Gastroenterology of ULB-Erasme Hospital and half time in the LGE on a translational IBD research project under supervision of Prof Denis Franchimont.

 
Joris Dutré, MD (ZNA, Belgium)
ZNA
 

 
Marc Ferrante, MD, PhD (UZ Leuven, Belgium)
UZ Leuven
 

 
Krisztina Gecse, MD, PhD (Amsterdam UMC, The Netherlands)
Amsterdam University Medical Center
 
Krisztina B. Gecse is a consultant gastroenterologist in the Amsterdam University Medical Center, Amsterdam in the Netherlands. Dr. Gecse completed a research fellowship at INRA-EI Purpan in Toulouse, France in 2007 and 2008, and she obtained her PhD at the University of Szeged, Hungary in 2012. She completed her medical training in internal medicine and subsequently in gastroenterology at the University of Szeged in Hungary and at the Academic Medical Center in Amsterdam. Dr Gecse has been a consultant first at the Semmelweis University in Budapest, Hungary and since 2017 in the Amsterdam UMC, where she is primarily engaged in clinical work in inflammatory bowel diseases, which is also the key focus of her research.
 
In 2008, Dr Gecse was awarded the Ray Clouse Prize by the Rome Foundation (USA) for “best research article in functional and GI motility disorders”. In 2014, she received the Merit Prize from Semmelweis University in Budapest, Hungary for “exceptional research and educational activity” and in 2015 Imre Magyar Prize by the Hungarian Society of Gastroenterology. In recent years, Dr Gecse has participated in several initiatives of the European Crohn’s Colitis Organization (ECCO) and is currently chairing the ECCO Clinical Research Committee. Dr Gecse has written articles in prominent scientific journals such as Nature Reviews Gastroenterology and Hepatology, Lancet Gastroenterology and Hepatology, Gut and Journal of Crohn’s and Colitis.

 
Evelien Humblet, MD (ZOL, Belgium)
ZOL
 

 
Triana Lobaton, MD, PhD (UZ Gent, Belgium)
UZ Gent
 

 
Edouard Louis, MD, PhD (CHU Liège, Belgium)
CHU Liège
 

 
Lieven Pouillon, MD (AZ Imelda, Bonheiden, Belgium)
AZ Imelda, Bonheiden
 
Lieven Pouillon graduated as a Medical Doctor in 2011 at the Catholic University of Leuven (Belgium), and finished his training as a Gastroenterologist in 2017, at the University Hospital Leuven (Belgium). His Master’s thesis (promotor: Prof. Dr. S. Vermeire) investigated the long-term outcome of the Trough Concentration Adapted Infliximab Treatment (TAXIT) trial. After finishing his internship, he fullfilled a 1-year fellowship at the IBD department of Prof. Dr. L. Peyrin-Biroulet in Nancy (France), where he participated both in clinical practice and in clinical research. Since August 2018, he started working as a full time staff member at the Department of Gastroenterology in Imeldaziekenhuis Bonheiden (Belgium), more specifically at the IBD Clinic and the GI Clinical Research Centre, one of the most dynamic and actively recruiting IBD research centres of Europe. So far, he has published > 25 peer-reviewed articles, of which > 15 as a first author. 

 
Jean-François Rahier, MD, PhD (CHU UCL Namur, Belgium)
CHU UCL Namur
 
Jean-François Rahier was born in Belgium in 1975. He obtained his diploma of medical doctor with cum laude in 2000 from the University of Louvain (UCL) and specialized in Gastroenterology in 2007. He was first trained by Pr O Dewit in Cliniques Universitaires Saint Luc in 2005 and then by Pr JF Colombel in Lille in 2006-2007. Besides, he had a part-time research activity in 2008-2013 at the INSERM U995 laboratory of Professor Desreumaux in Lille (France) where he obtained his PhD on “lymphangiogenesis in IBD” in 2014.
 
He is working at the University Hospital CHU UCL Namur in Belgium where his clinical activity is focused on inflammatory bowel disease (IBD) and also acted between 2014 and 2018 as consultant for phase II-III clinical trials in CHU Liège (Pr E Louis). In 2009 and 2014, he was the leading author for the European consensus on management and prevention of opportunistic infection in IBD. He has authored or co-authored around 50 peer-reviewed manuscript and is part of the scientific and executive committee of I-CARE. He is an active member of the Belgian IBD Group where he acts as President since 2017, of the European Crohn's and Colitis Organisation and of the GETAID (France).

 
Tim Raine, MB, BChir, PhD (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK)
Cambridge University Hospitals NHS Foundation Trust, Cambridge
 
Tim Raine is a consultant gastroenterologist at Addenbrooke’s Hospital, Cambridge, UK, where he leads the inflammatory bowel disease (IBD) service.
 
Tim has an active interest in human clinical trials in IBD and has worked as a chief investigator/principal investigator on a number of preclinical and clinical trials in IBD therapeutics, including first-in-human studies. He is the lead investigator for the major UK IASO trial in acute severe colitis. He is a member of the European Crohn’s and Colitis Organisation (ECCO) and sits on the ECCO guidelines committee; he is an author of several current ECCO guidelines and a project leader for the both Crohn’s and UC guidelines currently in development. He serves on the British Society of Gastroenterology (BSG) IBD Clinical Research Group, was awarded the BSG Young Gastroenterologist of the Year Award 2016, and is a group leader for the BSG IBD guidelines group.
 
He is an honorary faculty member of the Wellcome Trust Sanger Institute, Hinxton, UK. His research, funded by the Wellcome Trust, CCFA and the UK National Institute for Health Research (NIHR), focuses on understanding the regulation of the gastrointestinal immune system, in particular the immunological basis for genetic risk in IBD.

Frank Robben (Administrateur-generaal van het E-Health platform)
E-Health platform
 
Since 1991 Frank Robben is the general manager of the Crossroads Bank for Social Security, a public institution he conceived and founded, which ensures secure electronic data exchange between all actors in the social sector.
Since 2008, he is also the general manager of the eHealth platform, a public institution responsible for organising and supporting secure electronic data exchange between all actors in the health sector with a view to improving the quality of care and patient safety, reducing the administrative burden on patients and health care providers and supporting scientific research in the field of health. He also conceived and founded this institution.
Moreover, Frank Robben is CEO of Smals, the main ICT service provider in the Belgian social security sector, and is a member of the Belgian Data Protection Authority.
Frank was awarded the title of Flemish public manager of the year 2005.

 
Michael Somers, MD (UZA, Antwerpen, Belgium)
UZA, Antwerpen
 

 
Wouter Van Moerkercke, MD (AZ Groeninge, Kortrijk, Belgium)
AZ Groeninge, Kortrijk
 

 
Griet Verhenneman (UZ Leuven, Belgium)
UZ Leuven
 
Griet Verhenneman is a legal expert on eHealth. She has an academic background and has extensive experience in interdisciplinary research. Today Griet is Data Protection Officer at UZ Leuven (University hospital Catholic University Leuven) where she is responsible for advising care, research and HR departments on data protection. Before joining UZ Leuven as DPO, Griet was working as a researcher at the Centre for IT and IP Law at KU Leuven, where today she is an affiliated researcher. For 10 years she participated in numerous interdisciplinary research projects and several international conferences focussing on IT Law and Health. She covered a broad spectrum of topics such as EHRs, mHealth, telemedicine, clinical trials, genetics and genomics, but data protection and privacy have been the common thread in her research.

 
Séverine Vermeire, MD, PhD (UZ Leuven, Belgium)
UZ Leuven
 
Séverine Vermeire obtained her MD degree at the KU Leuven in 1995 and a PhD at the same University in 2001 on “Genetic Polymorphisms and Serologic Markers in Inflammatory Bowel Disease”. She further trained at the Universidad Nacional de Asuncion, Paraguay (1993), at the Wellcome Trust Centre for Human Genetics , University of Oxford (1997-1998) UK and at the Montreal General Hospital (McGill University) in Canada (2000–2001). Since 2003 she is staff member at the Gastroenterology Department of the University Hospitals Leuven and is appointed Professor of Medicine at the KU Leuven. Since 2016 she is Head of the Department of Chronic Diseases, Metabolism & Ageing (CHROMETA) at the KU Leuven.

Dr Vermeire is actively involved as principle investigator in RCTs with new therapeutic compounds and has been lead investigator on several of these programs. Her scientific work resulted in more than 400 peer-reviewed articles so far and focusses on the role of the microbiome and genetic susceptibility in IBD and on identifying predictive signatures of treatment response. She was awarded an Advanced ERC Grant from the EU in 2016.

She is Past-President of the Belgian IBD Research & Development (BIRD) Group and of the European Crohn’s and Colitis Organisation (ECCO).